A man given the drug Risperdal for autism grew unexpected larger breasts as a side effect. Because he was not warned of this possibility a jury awarded Nicholas Murray, 26, a whopping $8 billion from the drug company manufacturer Johnson & Johnson. Yes, that’s billion, with a B.
US drug firm Johnson & Johnson has been told to pay $8bn (£6.6bn) in punitive damages to a man over claims he was not warned that an anti-psychotic drug could lead to breast growth. A Philadelphia jury made the award to Nicholas Murray, 26, whose case was one of thousands pending in the state. His lawyers argued J&J’s subsidiary Janssen put “profits over patients” in marketing the drug Risperdal. J&J will appeal the ruling, which it said was “grossly disproportionate”. …
“A jury, if it’s outrageous enough conduct, will award a big number and let the lawyers and judges work it out,” …
Read more: BBC
A psychologist prescribed the drug after diagnosing him with autism spectrum disorder. In late 1993, the drug was approved by the Food and Drug Administration for treating schizophrenia and episodes of bipolar mania in adults.
Read more: InfoWrs
Mister Murray is young and he may have a lifetime of suffering as a result of this drug, but $8 billion? Well, the net worth of Johnson and Johnson is currently over $340 billion according to one source, so that may have been a factor for the jury.
Perhaps before the drug Mr Murray had a reasonable lifetime potential net worth of $8 billion based on not having man-boobs, who can say? He might have otherwise established a men’s fitness club empire, for example, with his ripped physique featured on billboards and magazines around the world.
With such a shocking initial award it will be interesting to see what he finally ends up with. Seems like it should be at least $8 million… perhaps $80 million… or could he end up with $800 million? With a $3 million breast reduction surgery, he’d still be set for life. Good luck to him.